Literature DB >> 26400640

The molecular genetics of the telomere biology disorders.

Alison A Bertuch1.   

Abstract

The importance of telomere function for human health is exemplified by a collection of Mendelian disorders referred to as the telomere biology disorders (TBDs), telomeropathies, or syndromes of telomere shortening. Collectively, the TBDs cover a spectrum of conditions from multisystem disease presenting in infancy to isolated disease presentations in adulthood, most notably idiopathic pulmonary fibrosis. Eleven genes have been found mutated in the TBDs to date, each of which is linked to some aspect of telomere maintenance. This review summarizes the molecular defects that result from mutations in these genes, highlighting recent advances, including the addition of PARN to the TBD gene family and the discovery of heterozygous mutations in RTEL1 as a cause of familial pulmonary fibrosis.

Entities:  

Keywords:  PARN; RTEL1; TERC; TERT; dyskeratosis congenita; hTR; idiopathic pulmonary fibrosis; telomerase; telomere; telomeropathy

Mesh:

Substances:

Year:  2015        PMID: 26400640      PMCID: PMC4993306          DOI: 10.1080/15476286.2015.1094596

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  129 in total

1.  CTC1 Mutations in a patient with dyskeratosis congenita.

Authors:  Rachel B Keller; Katelyn E Gagne; G Naheed Usmani; George K Asdourian; David A Williams; Inga Hofmann; Suneet Agarwal
Journal:  Pediatr Blood Cancer       Date:  2012-04-24       Impact factor: 3.167

2.  What are the essential symptoms in the Hoyeraal-Hreidarsson syndrome?

Authors:  S Ohga; T Kai; K Honda; H Nakayama; T Inamitsu; K Ueda
Journal:  Eur J Pediatr       Date:  1997-01       Impact factor: 3.183

3.  Telomerase activity in human germline and embryonic tissues and cells.

Authors:  W E Wright; M A Piatyszek; W E Rainey; W Byrd; J W Shay
Journal:  Dev Genet       Date:  1996

4.  Mutations in the telomere capping complex in bone marrow failure and related syndromes.

Authors:  Amanda J Walne; Tanya Bhagat; Michael Kirwan; Cyril Gitiaux; Isabelle Desguerre; Norma Leonard; Elena Nogales; Tom Vulliamy; Inderjeet S Dokal
Journal:  Haematologica       Date:  2012-08-16       Impact factor: 9.941

5.  hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.

Authors:  M Meyerson; C M Counter; E N Eaton; L W Ellisen; P Steiner; S D Caddle; L Ziaugra; R L Beijersbergen; M J Davidoff; Q Liu; S Bacchetti; D A Haber; R A Weinberg
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

6.  RTEL1 maintains genomic stability by suppressing homologous recombination.

Authors:  Louise J Barber; Jillian L Youds; Jordan D Ward; Michael J McIlwraith; Nigel J O'Neil; Mark I R Petalcorin; Julie S Martin; Spencer J Collis; Sharon B Cantor; Melissa Auclair; Heidi Tissenbaum; Stephen C West; Ann M Rose; Simon J Boulton
Journal:  Cell       Date:  2008-10-17       Impact factor: 41.582

7.  Conserved telomere maintenance component 1 interacts with STN1 and maintains chromosome ends in higher eukaryotes.

Authors:  Yulia V Surovtseva; Dmitri Churikov; Kara A Boltz; Xiangyu Song; Jonathan C Lamb; Ross Warrington; Katherine Leehy; Michelle Heacock; Carolyn M Price; Dorothy E Shippen
Journal:  Mol Cell       Date:  2009-10-23       Impact factor: 17.970

8.  Ancestral mutation in telomerase causes defects in repeat addition processivity and manifests as familial pulmonary fibrosis.

Authors:  Jonathan K Alder; Joy D Cogan; Andrew F Brown; Collin J Anderson; William E Lawson; Peter M Lansdorp; John A Phillips; James E Loyd; Julian J-L Chen; Mary Armanios
Journal:  PLoS Genet       Date:  2011-03-31       Impact factor: 5.917

9.  TRF1 negotiates TTAGGG repeat-associated replication problems by recruiting the BLM helicase and the TPP1/POT1 repressor of ATR signaling.

Authors:  Michal Zimmermann; Tatsuya Kibe; Shaheen Kabir; Titia de Lange
Journal:  Genes Dev       Date:  2014-10-24       Impact factor: 12.890

10.  TPP1 OB-fold domain controls telomere maintenance by recruiting telomerase to chromosome ends.

Authors:  Franklin L Zhong; Luis F Z Batista; Adam Freund; Matthew F Pech; Andrew S Venteicher; Steven E Artandi
Journal:  Cell       Date:  2012-08-03       Impact factor: 66.850

View more
  67 in total

1.  Small-Molecule PAPD5 Inhibitors Restore Telomerase Activity in Patient Stem Cells.

Authors:  Neha Nagpal; Jianing Wang; Jing Zeng; Emily Lo; Diane H Moon; Kevin Luk; Roman O Braun; Lauri M Burroughs; Sioban B Keel; Christopher Reilly; R Coleman Lindsley; Scot A Wolfe; Albert K Tai; Patrick Cahan; Daniel E Bauer; Yick W Fong; Suneet Agarwal
Journal:  Cell Stem Cell       Date:  2020-04-21       Impact factor: 24.633

2.  Similar telomere attrition rates in androgen-treated and untreated patients with dyskeratosis congenita.

Authors:  Payal P Khincha; Alison A Bertuch; Shahinaz M Gadalla; Neelam Giri; Blanche P Alter; Sharon A Savage
Journal:  Blood Adv       Date:  2018-06-12

3.  Pregnancy outcomes in mothers of offspring with inherited bone marrow failure syndromes.

Authors:  Neelam Giri; Helen D Reed; Pamela Stratton; Sharon A Savage; Blanche P Alter
Journal:  Pediatr Blood Cancer       Date:  2017-08-12       Impact factor: 3.167

Review 4.  Genetic predisposition to MDS: clinical features and clonal evolution.

Authors:  Alyssa L Kennedy; Akiko Shimamura
Journal:  Blood       Date:  2019-01-22       Impact factor: 22.113

5.  From incomplete penetrance with normal telomere length to severe disease and telomere shortening in a family with monoallelic and biallelic PARN pathogenic variants.

Authors:  Lois M Dodson; Alessandro Baldan; Mikael Nissbeck; Sethu M R Gunja; Penelope E Bonnen; Geraldine Aubert; Sherri Birchansky; Anders Virtanen; Alison A Bertuch
Journal:  Hum Mutat       Date:  2019-09-15       Impact factor: 4.878

6.  Pulmonary arteriovenous malformations: an uncharacterised phenotype of dyskeratosis congenita and related telomere biology disorders.

Authors:  Payal P Khincha; Alison A Bertuch; Suneet Agarwal; Danielle M Townsley; Neal S Young; Siobán Keel; Akiko Shimamura; Farid Boulad; Tregony Simoneau; Henri Justino; Christin Kuo; Steven Artandi; Charles McCaslin; Des W Cox; Sara Chaffee; Bridget F Collins; Neelam Giri; Blanche P Alter; Ganesh Raghu; Sharon A Savage
Journal:  Eur Respir J       Date:  2017-01-25       Impact factor: 16.671

7.  Telomere dysfunction cooperates with epigenetic alterations to impair murine embryonic stem cell fate commitment.

Authors:  Aditi Qamra; Tsz Wai Chu; Mélanie Criqui; Monika Sharma; Julissa Tsao; Danielle A Henry; Dalia Barsyte-Lovejoy; Cheryl H Arrowsmith; Neil Winegarden; Mathieu Lupien; Lea Harrington
Journal:  Elife       Date:  2020-04-16       Impact factor: 8.140

Review 8.  A regulatory loop connecting WNT signaling and telomere capping: possible therapeutic implications for dyskeratosis congenita.

Authors:  Rafael Jesus Fernandez; F Brad Johnson
Journal:  Ann N Y Acad Sci       Date:  2018-04       Impact factor: 5.691

9.  Investigation of chromosome X inactivation and clinical phenotypes in female carriers of DKC1 mutations.

Authors:  Jialin Xu; Payal P Khincha; Neelam Giri; Blanche P Alter; Sharon A Savage; Judy M Y Wong
Journal:  Am J Hematol       Date:  2016-11-04       Impact factor: 10.047

10.  Clonal hematopoiesis in patients with dyskeratosis congenita.

Authors:  Nieves Perdigones; Juan C Perin; Irene Schiano; Peter Nicholas; Jaclyn A Biegel; Philip J Mason; Daria V Babushok; Monica Bessler
Journal:  Am J Hematol       Date:  2016-10-21       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.